BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35162942)

  • 1. Decreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma.
    Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gene expression of GPER1 is low in fresh samples of papillary thyroid carcinoma (PTC), and in silico analysis.
    Bertoni APS; Manfroi PA; Tomedi J; Assis-Brasil BM; de Souza Meyer EL; Furlanetto TW
    Mol Cell Endocrinol; 2021 Sep; 535():111397. PubMed ID: 34273443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Tang C; Yang L; Wang N; Li L; Xu M; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2014; 7(6):3213-23. PubMed ID: 25031742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of ERβ 5'-untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer.
    Xu LW; Gou X; Yang JY; Jiang R; Jiang X; Chen GG; Liu ZM
    FASEB J; 2021 Apr; 35(4):e21516. PubMed ID: 33710697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
    Ahn HY; Song RY; Ahn HS; Kim HS
    Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.
    Dai YJ; Qiu YB; Jiang R; Xu M; Zhao L; Chen GG; Liu ZM
    Sci Rep; 2017 Sep; 7(1):12279. PubMed ID: 28947799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
    Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
    Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
    Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
    Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.
    Yi JW; Kim SJ; Kim JK; Seong CY; Yu HW; Chai YJ; Choi JY; Lee KE
    Ann Surg Oncol; 2017 Nov; 24(12):3754-3762. PubMed ID: 28124274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
    Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
    Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology.
    Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA
    Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
    Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
    Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
    Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
    Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
    BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway.
    Zhang Y; Wei F; Zhang J; Hao L; Jiang J; Dang L; Mei D; Fan S; Yu Y; Jiang L
    Arch Biochem Biophys; 2017 Nov; 633():29-39. PubMed ID: 28882636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion, lower pathological tumor stages, and prolonged disease-free survival in papillary thyroid carcinoma patients.
    Ding H; Wang X; Liu H; Na L
    J Clin Lab Anal; 2021 Jul; 35(7):e23819. PubMed ID: 33969549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
    Wu YC; Li SY; Jia YF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.